{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:41:19Z","timestamp":1793749279457,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Association Jules Bordet","award":["Grant 2022-11"],"award-info":[{"award-number":["Grant 2022-11"]}]},{"name":"Renew Pharmaceuticals Limited \/ Diagnostic Green","award":["2023.06.01"],"award-info":[{"award-number":["2023.06.01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09577-8","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:24:34Z","timestamp":1772504674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intraoperative breast cancer margin evaluation using fluorescence imaging with intravenous injection of indocyanine green (BREASTIFLU-1): study protocol for a randomized diagnostic accuracy trial of quantitative dose-timing assessment"],"prefix":"10.1186","volume":"27","author":[{"given":"C. Florin","family":"Pop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Veys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro","family":"De Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Larsimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"9577_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"9577_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamasurg.2021.1438","volume":"156","author":"J de Boniface","year":"2021","unstructured":"de Boniface J, Szulkin R, Johansson ALV. Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: a Swedish national 6-year follow-up of 48\u202f986 women. JAMA Surg. 2021;156(7):628\u201337. https:\/\/doi.org\/10.1001\/jamasurg.2021.1438.","journal-title":"JAMA Surg"},{"key":"9577_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820976667","volume":"27","author":"P Yu","year":"2020","unstructured":"Yu P, Tang H, Zou Y, Liu P, Tian W, Zhang K, et al. Breast-conserving therapy versus mastectomy in young breast cancer patients concerning molecular subtypes: a SEER population-based study. Cancer Control. 2020;27:1073274820976667. https:\/\/doi.org\/10.1177\/1073274820976667.","journal-title":"Cancer Control"},{"issue":"2","key":"9577_CR4","doi-asserted-by":"publisher","DOI":"10.53388\/TMRC201800099","volume":"4","author":"H Chen","year":"2021","unstructured":"Chen H, Wei DY. Bibliometrics analysis of psychological intervention in breast cancer patients. Cancer Adv. 2021;4(2):9. https:\/\/doi.org\/10.53388\/TMRC201800099.","journal-title":"Cancer Adv"},{"key":"9577_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejca.2017.07.032","volume":"84","author":"S Tang","year":"2017","unstructured":"Tang S, Kaptanis S, Haddow J, Mondani G, Elsberger B, Tasoulis MK, et al. Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland. Eur J Cancer. 2017;84:315\u201324. https:\/\/doi.org\/10.1016\/j.ejca.2017.07.032.","journal-title":"Eur J Cancer"},{"key":"9577_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1245\/s10434-014-3481-4","volume":"21","author":"MS Moran","year":"2014","unstructured":"Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of surgical oncology American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21:704\u201316. https:\/\/doi.org\/10.1245\/s10434-014-3481-4.","journal-title":"Ann Surg Oncol"},{"key":"9577_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/SLA.0000000000001897","volume":"265","author":"E St John","year":"2017","unstructured":"St John E, Al-Khudairi R, Ashrafian H, Athanasiou T, Takats Z, Hadjiminas DJ, et al. Diagnostic accuracy of intraoperative techniques for margin assessment in breast cancer surgery: a meta-analysis. Ann Surg. 2017;265:300\u201310. https:\/\/doi.org\/10.1097\/SLA.0000000000001897.","journal-title":"Ann Surg"},{"issue":"1","key":"9577_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1245\/s10434-016-5756-4","volume":"25","author":"RJ Gray","year":"2018","unstructured":"Gray RJ, Pockaj BA, Garvey E, Blair S. Intraoperative margin management in breast-conserving surgery: a systematic review of the literature. Ann Surg Oncol. 2018;25(1):18\u201327. https:\/\/doi.org\/10.1245\/s10434-016-5756-4.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9577_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/1073274817752332","volume":"25","author":"KS Samkoe","year":"2018","unstructured":"Samkoe KS, Bates BD, Elliott JT, LaRochelle E, Gunn JR, Marra K, et al. Application of fluorescence-guided surgery to subsurface cancers requiring wide local excision: literature review and novel developments toward indirect visualization. Cancer Control. 2018;25(1):1073274817752332. https:\/\/doi.org\/10.1177\/1073274817752332.","journal-title":"Cancer Control"},{"issue":"5","key":"9577_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/ot9.0000000000000056","volume":"10","author":"Y Li","year":"2024","unstructured":"Li Y, Wu M, Ma X, Li Z, Wang T, Gao X. Optical molecular imaging in cancer research: current impact and future prospect. Oncology and Translational Medicine. 2024;10(5):212\u201322. https:\/\/doi.org\/10.1097\/ot9.0000000000000056.","journal-title":"Oncology and Translational Medicine"},{"key":"9577_CR11","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/cncr.24291","volume":"115","author":"T Ishizawa","year":"2009","unstructured":"Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115:2491\u2013504. https:\/\/doi.org\/10.1002\/cncr.24291.","journal-title":"Cancer"},{"key":"9577_CR12","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/SLA.0000000000001618","volume":"264","author":"G Liberale","year":"2016","unstructured":"Liberale G, Vankerckhove S, Galdon MG, Ahmed B, Moreau M, Nakadi IE, et al. Fluorescence imaging after indocyanine green injection for detection of peritoneal metastases in patients undergoing cytoreductive surgery for peritoneal carcinomatosis from colorectal cancer: a pilot study. Ann Surg. 2016;264:1110\u20135. https:\/\/doi.org\/10.1097\/SLA.0000000000001618.","journal-title":"Ann Surg"},{"key":"9577_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197857","volume":"13","author":"I Veys","year":"2018","unstructured":"Veys I, Pop CF, Barbieux R, Moreau M, Noterman D, De Neubourg F, et al. ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy. PLoS One. 2018;13:e0197857. https:\/\/doi.org\/10.1371\/journal.pone.0197857.","journal-title":"PLoS One"},{"key":"9577_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jso.24167","volume":"113","author":"J Keating","year":"2016","unstructured":"Keating J, Tchou J, Okusanya O, Fisher C, Batiste R, Jiang J, et al. Identification of breast cancer margins using intraoperative near-infrared imaging. J Surg Oncol. 2016;113:508\u201314. https:\/\/doi.org\/10.1002\/jso.24167.","journal-title":"J Surg Oncol"},{"issue":"2","key":"9577_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejso.2020.09.036","volume":"47","author":"FC Pop","year":"2021","unstructured":"Pop FC, Veys I, Vankerckhove S, Barbieux R, Chintinne M, Moreau M, et al. Absence of residual fluorescence in the surgical bed at near-infrared fluorescence imaging predicts negative margins at final pathology in patients treated with breast-conserving surgery for breast cancer. Eur J Surg Oncol. 2021;47(2):269\u201375. https:\/\/doi.org\/10.1016\/j.ejso.2020.09.036.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"9577_CR16","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1245\/s10434-021-10503-2","volume":"28","author":"MS Kedrzycki","year":"2021","unstructured":"Kedrzycki MS, Leiloglou M, Chalau V, Chiarini N, Thiruchelvam PTR, Hadjiminas DJ, et al. The impact of temporal variation in indocyanine green administration on tumor identification during fluorescence guided breast surgery. Ann Surg Oncol. 2021;28(10):5617\u201325. https:\/\/doi.org\/10.1245\/s10434-021-10503-2.","journal-title":"Ann Surg Oncol"},{"key":"9577_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271\u201384. https:\/\/doi.org\/10.1016\/s0168-3659(99)00248-5.","journal-title":"J Control Release"},{"key":"9577_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1088\/0031-9155\/53\/4\/002","volume":"53","author":"B Alacam","year":"2008","unstructured":"Alacam B, Yazici B, Intes X, Nioka S, Chance B. Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods. Phys Med Biol. 2008;53:837\u201359. https:\/\/doi.org\/10.1088\/0031-9155\/53\/4\/002.","journal-title":"Phys Med Biol"},{"key":"9577_CR19","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1073\/pnas.040570597","volume":"97","author":"B Alacam","year":"2000","unstructured":"Alacam B, Yodh AG, Schnall M, Chance B. Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods. Phys Med Biol. 2000;97:2767\u201372. https:\/\/doi.org\/10.1073\/pnas.040570597.","journal-title":"Phys Med Biol"},{"issue":"3","key":"9577_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-023-07199-1","volume":"204","author":"CF Pop","year":"2024","unstructured":"Pop CF, Veys I, Bormans A, Larsimont D, Liberale G. Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies. Breast Cancer Res Treat. 2024;204(3):429\u201342. https:\/\/doi.org\/10.1007\/s10549-023-07199-1.","journal-title":"Breast Cancer Res Treat"},{"key":"9577_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ijc.30102","volume":"139","author":"N Onda","year":"2016","unstructured":"Onda N, Kimura M, Yoshida T, Shibutani M. Preferential tumor cellular uptake and retention of indocyanine green for in vivo tumor imaging. Int J Cancer. 2016;139:673\u201382. https:\/\/doi.org\/10.1002\/ijc.30102.","journal-title":"Int J Cancer"},{"key":"9577_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.05.438013","author":"CD Chan","year":"2021","unstructured":"Chan CD, Brookes MJ, Tanwani R, Hope C, Pringle TA, Knight JC. Investigating the mechanisms of indocyanine green (ICG) cellular uptake in sarcoma. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.04.05.438013.","journal-title":"bioRxiv"},{"key":"9577_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-022-02827-4","volume":"20","author":"Y Wang","year":"2022","unstructured":"Wang Y, Jiao W, Yin Z, Zhao W, Zhao K, Zhou Y, et al. Application of near-infrared fluorescence imaging in the accurate assessment of surgical margins during breast-conserving surgery. World J Surg Oncol. 2022;20:357. https:\/\/doi.org\/10.1186\/s12957-022-02827-4.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"9577_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med"},{"key":"9577_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4082501","volume":"18","author":"E El-Helou","year":"2023","unstructured":"El-Helou E, Eddy C, Picchia S, de Van Merckt C, Radermeker M, Moreau M, et al. Effectiveness of carbon localization for invasive breast cancer: an institutional experience. Breast J. 2023;18:4082501. https:\/\/doi.org\/10.1155\/2023\/4082501.","journal-title":"Breast J"},{"key":"9577_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cct.2015.07.016","volume":"45","author":"V Vickerstaff","year":"2015","unstructured":"Vickerstaff V, Ambler G, King M, Nazareth I, Omar RZ. Are multiple primary outcomes analysed appropriately in randomised controlled trials? A review. Contemp Clin Trials. 2015;45:8\u201312. https:\/\/doi.org\/10.1016\/j.cct.2015.07.016.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"9577_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989;10(1):1\u201310. https:\/\/doi.org\/10.1016\/0197-2456(89)90015-9.","journal-title":"Control Clin Trials"},{"issue":"12","key":"9577_CR28","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41551-023-01105-2","volume":"7","author":"R Pal","year":"2023","unstructured":"Pal R, Lwin TM, Krishnamoorthy M, Collins HR, Chan CD, Prilutskiy A, et al. Fluorescence lifetime of injected indocyanine green as a universal marker of solid tumours in patients. Nat Biomed Eng. 2023;7(12):1649\u201366. https:\/\/doi.org\/10.1038\/s41551-023-01105-2.","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"9577_CR29","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s00464-023-10564-2","volume":"38","author":"J Dalli","year":"2024","unstructured":"Dalli J, Joosten JJ, Jindal A, Hardy NP, Camilleri-Brennan J, Andrejevic P, et al. Impact of standardising indocyanine green fluorescence angiography technique for visual and quantitative interpretation on interuser variability in colorectal surgery. Surg Endosc. 2024;38(3):1306\u201315. https:\/\/doi.org\/10.1007\/s00464-023-10564-2.","journal-title":"Surg Endosc"},{"issue":"2","key":"9577_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12539-022-00515-1","volume":"14","author":"R Das","year":"2022","unstructured":"Das R, Kaur K, Walia E. Feature generalization for breast cancer detection in histopathological images. Interdiscip Sci Comput Life Sci. 2022;14(2):566\u201381. https:\/\/doi.org\/10.1007\/s12539-022-00515-1.","journal-title":"Interdiscip Sci Comput Life Sci"},{"issue":"1","key":"9577_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/med4.51","volume":"2","author":"R Sharma","year":"2024","unstructured":"Sharma R, Malviya R. Modifying the electrical, optical, and magnetic properties of cancer cells: a comprehensive approach for cancer management. Medicine Advances. 2024;2(1):3\u201319. https:\/\/doi.org\/10.1002\/med4.51.","journal-title":"Medicine Advances"},{"issue":"11","key":"9577_CR32","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","volume":"34","author":"G Curigliano","year":"2023","unstructured":"Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM, et al. Understanding breast cancer complexity to improve patient outcomes: the St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol. 2023;34(11):970\u201386. https:\/\/doi.org\/10.1016\/j.annonc.2023.08.017.","journal-title":"Ann Oncol"},{"issue":"1","key":"9577_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13063-022-06316-7","volume":"23","author":"R Qureshi","year":"2022","unstructured":"Qureshi R, Gough A, Loudon K. The SPIRIT checklist-lessons from the experience of SPIRIT protocol editors. Trials. 2022;23(1):359. https:\/\/doi.org\/10.1186\/s13063-022-06316-7.","journal-title":"Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09577-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:42:18Z","timestamp":1775738538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09577-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9577"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09577-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study will be conducted in accordance with the principles of the Declaration of Helsinki on Medical Research Involving Human Subjects Act and in accordance with International Good Clinical Practice guidelines. The study protocol has received medical-ethical approval by the Belgian Ethics Authority and by the Belgian Federal Agency for Medicines and Health Products under the number 3608\/2023\/12\/2. Protocol version 1.1 was approved on December 21, 2023. Written consent is obtained from each participant before enrollment. Participants are aware of the purpose, the fact that they have no direct advantages, and the risks of the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}